Chest PNF on Pulmonary Function in Parkinson Disease

Subhasish Chatterjee20 enrolled

Overview

Background: Parkinson disease (PD) is a progressive neurodegenerative disorder and characterized by tremor, rigidity and bradykinesia. Almost 84% of PD patient develops respiratory abnormalities and pointed as the most common cause of death. Airway obstruction, trunk muscle rigidity is the common cause of respiratory abnormalities. Purpose: The main purpose of the study will evaluate the efficacy of chest PNF on pulmonary function and chest wall mobility in PD. Methods: 20 participants will be recruited for study purpose and divide into two groups. Group= A will be the control group and participants will receive conventional treatment which includes deep breathing exercise and segmental breathing exercise, incentive spirometry etc for one week. Group= B participants will receive chest PNF exercise along with conventional treatment for a week. Pretreatment and post-treatment data will be recorded by the help of PFT (FVC, FEV1 \& FEV1/FVC) and chest wall expansion at axillary and xiphisternal level for data analysis. Data analysis will be done by paired t-test for within group and independent t-test will be used for the between-group variable. The level of significance will be set at 0.05.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Parkinson Disease

Interventions

chest PNFOTHER

Chest PNF technique includes oblique downward pressure at sternum, diagonal pressure at lower rib cage at supine line, caudal medial pressure at side lying, Caudal pressure at ribcage at prone lying, dorsal and caudal pressure at prone on elbow.

ConventionalOTHER

conventional chest physiotherapy treatment, which includes Deep breathing exercise, Diaphragmatic breathing exercise, segmental breathing exercise and purse lip breathing and incentive spirometer

Eligibility

Sex: ALLMin age: 50 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Grade 3 to grade 5 Parkinson patients according to Hoehn Yahar scale 2. MMSE score \>23. 3. Age 50-70 yrs. 4. Both Male and Female. Exclusion Criteria: 1. Previous history of cardiac and pulmonary surgery. 2. History of flail chest. 3. Individual affected by neurological disorder other than PD. 4. Uncooperative patients. 5. Individual with the psychosomatic disorder.

Outcomes

Primary Outcomes

Pulmonary Function Test (PFT)

Pulmonary functions parameters FVC in litre, FEV1 in litre and ratio between FVC/FEV1 will be recorded with PFT

Time frame: changes bwtween baseline to 1 week

Secondary Outcomes

chest wall expansion by inch tape

chest wall expansion will be measured at axillary and xiphisternal level